Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

BACKGROUND: Molecular characterization of prostate cancer (PCa) has revealed distinct subclasses based on underlying genomic alterations occurring early in the natural history of the disease. However, how these early alterations influence subsequent molecular events and the course of the disease ove...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Invest
Главные авторы: Liu, Deli, Augello, Michael A., Grbesa, Ivana, Prandi, Davide, Liu, Yang, Shoag, Jonathan E., Karnes, R. Jeffrey, Trock, Bruce J., Klein, Eric A., Den, Robert B., Demichelis, Francesca, Davicioni, Elai, Sboner, Andrea, Barbieri, Christopher E.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Clinical Investigation 2021
Предметы:
Clinical Medicine
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8121518/
https://ncbi.nlm.nih.gov/pubmed/33998599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI147878
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы